Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hatherill

Showing results (151-160 of 222) with videos related to

Pageof 23
Sort By:
American Journal of Respiratory and Critical Care Medicine|August 10, 2018
Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection TrialSara Suliman, Angelique Kany Kany Luabeya, Hennie Geldenhuys, et al.
The Journal of Infectious Diseases|June 28, 2008
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South AfricaTony Hawkridge, Thomas J Scriba, Sebastian Gelderbloem, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 2016
Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell ResponsesSara Suliman, Hennie Geldenhuys, John L Johnson, et al.
BMC Medicine|May 18, 2016
Human newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control studyHelen A Fletcher, Ali Filali-Mouhim, Elisa Nemes, et al.
The Lancet. Infectious Diseases|June 30, 2025
The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?Jason R Andrews, Salome Charalambous, Gavin Churchyard, et al.
Frontiers in Immunology|October 9, 2024
Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humansAndrew Fiore-Gartland, Himangi Srivastava, Aaron Seese, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Blood transcriptomic signatures predict poor outcomes in drug-susceptible pulmonary TB in BrazilSimon C Mendelsohn, Bruno B Andrade, Mariana Araújo-Pereira, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Blood transcriptomic signatures predict poor treatment outcomes in drug-susceptible pulmonary TB in BrazilSimon C Mendelsohn, Bruno B Andrade, Mariana Araújo-Pereira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2020
Immune Profiling Enables Stratification of Patients With Active Tuberculosis Disease or Mycobacterium tuberculosis InfectionDarragh Duffy, Elisa Nemes, Alba Llibre, et al.
Frontiers in Immunology|October 12, 2020
Postnatal Expansion, Maturation, and Functionality of MR1T Cells in HumansGwendolyn M Swarbrick, Anele Gela, Meghan E Cansler, et al.
Pageof 23

Showing results (151-160 of 222) with videos related to

Sort By:
Pageof 23
American Journal of Respiratory and Critical Care Medicine|August 10, 2018
Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection TrialSara Suliman, Angelique Kany Kany Luabeya, Hennie Geldenhuys, et al.
The Journal of Infectious Diseases|June 28, 2008
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South AfricaTony Hawkridge, Thomas J Scriba, Sebastian Gelderbloem, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 2016
Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell ResponsesSara Suliman, Hennie Geldenhuys, John L Johnson, et al.
BMC Medicine|May 18, 2016
Human newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control studyHelen A Fletcher, Ali Filali-Mouhim, Elisa Nemes, et al.
The Lancet. Infectious Diseases|June 30, 2025
The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?Jason R Andrews, Salome Charalambous, Gavin Churchyard, et al.
Frontiers in Immunology|October 9, 2024
Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humansAndrew Fiore-Gartland, Himangi Srivastava, Aaron Seese, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Blood transcriptomic signatures predict poor outcomes in drug-susceptible pulmonary TB in BrazilSimon C Mendelsohn, Bruno B Andrade, Mariana Araújo-Pereira, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Blood transcriptomic signatures predict poor treatment outcomes in drug-susceptible pulmonary TB in BrazilSimon C Mendelsohn, Bruno B Andrade, Mariana Araújo-Pereira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2020
Immune Profiling Enables Stratification of Patients With Active Tuberculosis Disease or Mycobacterium tuberculosis InfectionDarragh Duffy, Elisa Nemes, Alba Llibre, et al.
Frontiers in Immunology|October 12, 2020
Postnatal Expansion, Maturation, and Functionality of MR1T Cells in HumansGwendolyn M Swarbrick, Anele Gela, Meghan E Cansler, et al.
Pageof 23